Q4 2026 edition
The CIFoundry Clinical AI Index
See how much of medical AI is on the public record. Each quarter we count the tools in our directory and how many have the facts buyers ask about first: an Epic integration, health systems named as users, a published study and FDA authorization.
Data as of November 22, 2026, drawn directly from the directory. No scores, no rankings.
Headline numbers
Quarter-over-quarter changes start with the Q1 2027 edition. Our team has also matched 190 tools to entries in the public FDA database, and from vendors’ own websites we have recorded that 46 sign a BAA and 68 make a SOC 2 statement (including “in progress”).
By specialty
Share of each area’s tools with the fact on record. Sorted by number of tools.
| Area | Tools | Epic integration | Named users | Published study | FDA authorized |
|---|---|---|---|---|---|
| NLP & EHR | 127 | 32% | 15% | 2% | 0% |
| Radiology | 84 | 2% | 13% | 6% | 62% |
| Revenue Cycle & Prior Auth | 80 | 48% | 8% | 0% | 1% |
| Triage & Patient Access | 73 | 48% | 12% | 1% | 0% |
| Cardiology | 72 | 6% | 18% | 8% | 69% |
| General | 62 | 52% | 13% | 0% | 3% |
| Hospital Operations | 48 | 31% | 23% | 0% | 0% |
| Drug Discovery | 41 | 12% | 2% | 5% | 0% |
| Oncology | 38 | 13% | 18% | 11% | 42% |
| Neurology | 37 | 8% | 19% | 5% | 70% |
| Hospital Medicine & Critical Care | 37 | 51% | 30% | 19% | 16% |
| Mental Health | 28 | 4% | 11% | 7% | 0% |
| Pathology | 27 | 0% | 19% | 7% | 22% |
| Dermatology | 24 | 13% | 13% | 13% | 13% |
| Population Health & Value-Based Care | 19 | 5% | 0% | 0% | 0% |
| Surgery | 17 | 6% | 18% | 0% | 53% |
| Home Health & Post-Acute | 16 | 0% | 0% | 0% | 6% |
| Endocrinology | 15 | 7% | 7% | 7% | 73% |
| Pulmonology | 14 | 7% | 29% | 0% | 86% |
| Ophthalmology | 14 | 21% | 21% | 43% | 50% |
| Orthopedics | 13 | 0% | 8% | 0% | 69% |
| Physical Therapy & Rehab | 13 | 8% | 15% | 0% | 8% |
| Women's Health & OB-GYN | 13 | 15% | 0% | 0% | 38% |
| Remote Monitoring & Hospital at Home | 12 | 8% | 0% | 0% | 25% |
| Lab, Genomics & Diagnostics | 11 | 0% | 0% | 0% | 0% |
| Pharmacy & Medication Safety | 10 | 20% | 0% | 0% | 0% |
| Clinical Trials | 9 | 0% | 11% | 0% | 0% |
| Gastroenterology | 6 | 0% | 83% | 0% | 83% |
| AI Governance & Security | 5 | 0% | 0% | 0% | 0% |
| Nephrology | 3 | 33% | 0% | 0% | 33% |
By use case
The categories buyers search for most. Each links to its shortlists and fact table.
| Area | Tools | Epic integration | Named users | Published study | FDA authorized |
|---|---|---|---|---|---|
| Ambient AI scribes | 68 | 40% | 21% | 3% | 0% |
| Patient scheduling & intake AI | 32 | 38% | 9% | 0% | 0% |
| Healthcare voice AI agents | 26 | 65% | 15% | 0% | 0% |
| AI medical coding & CDI | 25 | 76% | 16% | 0% | 0% |
| Denials & claims management AI | 19 | 42% | 5% | 0% | 0% |
| Prior authorization AI | 15 | 53% | 0% | 0% | 0% |
| EHR AI copilots & assistants | 14 | 36% | 21% | 0% | 0% |
| Sepsis & deterioration early-warning AI | 13 | 38% | 54% | 54% | 31% |
| AI symptom checkers & triage | 12 | 42% | 17% | 8% | 0% |
| Chart summarization AI | 11 | 9% | 9% | 0% | 0% |
| Virtual nursing & patient observation AI | 10 | 80% | 30% | 0% | 0% |
How to read the Index
The Index counts what is on the public record for tools listed in CIFoundry, not clinical quality. A low share means fewer facts are documented publicly, not that the tools are worse. Tools we can’t trace to a public source aren’t listed, so the counts cover our directory, not the whole market.
An Epic integration means an Epic Showroom listing or an integration stated in the listing. Named users are health systems named in news reports or press releases. A published study is a journal article, conference abstract, registered trial or preprint about the tool; FDA summaries and vendor pages don’t count. FDA authorized means the listing states a 510(k) clearance, De Novo or approval.
Full definitions are in how we review listings. You’re welcome to cite the Index; please link to this page. Something wrong? Use “Request a correction” on any tool page.